eflornithine has been researched along with Osteogenic Sarcoma in 2 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Setty, BA | 1 |
| Jin, Y | 1 |
| Houghton, PJ | 1 |
| Yeager, ND | 1 |
| Gross, TG | 1 |
| Nelin, LD | 1 |
| Goto, H | 1 |
| Matsui-Yuasa, I | 1 |
| Otani, S | 1 |
| Morisawa, S | 1 |
| Nishizawa, Y | 1 |
| Morii, H | 1 |
2 other studies available for eflornithine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Hypoxic Proliferation of Osteosarcoma Cells Depends on Arginase II.
Topics: Arginase; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Eflo | 2016 |
Effects of parathyroid hormone on ornithine decarboxylase activity in human osteosarcoma cells.
Topics: Bucladesine; Butyrates; Butyric Acid; Cell Line; Cyclic AMP; DNA Replication; Eflornithine; Humans; | 1991 |